AU2071295A - Assay for monitoring the progress of chronic myelogenous leukemia - Google Patents

Assay for monitoring the progress of chronic myelogenous leukemia

Info

Publication number
AU2071295A
AU2071295A AU20712/95A AU2071295A AU2071295A AU 2071295 A AU2071295 A AU 2071295A AU 20712/95 A AU20712/95 A AU 20712/95A AU 2071295 A AU2071295 A AU 2071295A AU 2071295 A AU2071295 A AU 2071295A
Authority
AU
Australia
Prior art keywords
assay
progress
monitoring
myelogenous leukemia
chronic myelogenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20712/95A
Inventor
Ayelet Avraham
Yinon Ben-Neriah
Dina Ben-Yehuda
Michal Zion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Publication of AU2071295A publication Critical patent/AU2071295A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
AU20712/95A 1994-03-15 1995-03-15 Assay for monitoring the progress of chronic myelogenous leukemia Abandoned AU2071295A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL108978 1994-03-15
IL108978A IL108978A (en) 1994-03-15 1994-03-15 Assay for monitoring the progress of cml
PCT/EP1995/000966 WO1995025176A1 (en) 1994-03-15 1995-03-15 Assay for monitoring the progress of chronic myelogenous leukemia

Publications (1)

Publication Number Publication Date
AU2071295A true AU2071295A (en) 1995-10-03

Family

ID=11065934

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20712/95A Abandoned AU2071295A (en) 1994-03-15 1995-03-15 Assay for monitoring the progress of chronic myelogenous leukemia

Country Status (3)

Country Link
AU (1) AU2071295A (en)
IL (1) IL108978A (en)
WO (1) WO1995025176A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017704A (en) * 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
EP1009865A1 (en) * 1997-08-29 2000-06-21 Osvaldo J. Lopez Dna methyltransferase genotyping
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US7208010B2 (en) 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
AU4609301A (en) * 1999-11-02 2001-05-14 Curagen Corporation Method of identifying a nucleic acid sequence
EP1582180B1 (en) 2000-10-16 2008-02-27 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057410A (en) * 1988-08-05 1991-10-15 Cetus Corporation Chimeric messenger RNA detection methods

Also Published As

Publication number Publication date
WO1995025176A1 (en) 1995-09-21
IL108978A (en) 1998-02-22
IL108978A0 (en) 1994-06-24

Similar Documents

Publication Publication Date Title
AU2916695A (en) Localizer
AU4232596A (en) Peelable laminate
AU4036895A (en) Substituted 1H-imidazoles
AU2686995A (en) Position transducer
AU2805195A (en) Therapeutic compounds
AU3190495A (en) Transmitter-receiver
AU1542895A (en) Surface treatment
AU2844595A (en) Substituted biphenyloxazolines
AUPM464594A0 (en) Drill configuration
AU2786295A (en) Spacing member
AU6047099A (en) Compositions and methods for the treatment of chronic lymphocytic leukemia
AU1907095A (en) Spacing member
AU2071295A (en) Assay for monitoring the progress of chronic myelogenous leukemia
AU2114295A (en) Manipulator-arm for auxiliary-tool for the joining of drillpipe
AU4713596A (en) Assay apparatus
AU2577495A (en) Cephalosporin compounds and processes for the preparation thereof
AU3417895A (en) Chronic myelogenous leukemia diagnostic assay
AU8095598A (en) Hair-drier or the like
AU3856995A (en) UCF116 Compounds
AU7713894A (en) Wagering
AU2360595A (en) Use of benzylidene-malononitrile derivates for the treatment of leukemia
AU2671895A (en) Bisquinolines for the treatment of malaria
AU2301295A (en) Guanidino-substituted compounds
AU7178194A (en) Assay for total bilirubin
AU3907595A (en) Column hoists